Dr. Georges Nemer
Professor of Genomics and Translational Biomedicine
College of Health and Life Sciences
Hamad Bin Khalifa University (HBKU), Doha, Qatar
Dr. Georges Nemer is a distinguished Professor of Genomics and Translational Biomedicine at the College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Doha, Qatar. He earned his PhD in Pharmacology from the Université de Montréal, Canada, and has since built a formidable career in academia and research, emphasizing precision medicine, molecular genetics, and genomics.
Dr. Nemer has held pivotal roles in academic leadership, including serving as Interim Dean of HBKU’s College of Health and Life Sciences (2022-2023), Associate Dean for Research (2023-2025), and heading the Genomics and Translational Biomedicine division (2019-2022). Prior to joining HBKU, he was a professor at the American University of Beirut (AUB), where he directed the Molecular Core Facility and co-directed the Congenital Heart Disease Genetic Program, among other influential positions.
A prolific researcher, Dr. Nemer has contributed extensively to the understanding of the genetic and molecular mechanisms underlying rare and common diseases. His work, particularly in congenital heart defects, cardio-cutaneous syndromes, hypercholesterolemia, and vitamin D deficiency, is widely published in leading peer-reviewed journals. He mentored more than 45 graduate students and 20 postdocs in biochemistry and molecular genetics, in addition to 16 classes of Med I students.
He has published over 150 papers and book chapters in areas related to Congenital Heart Diseases and other inherited rare genetic disorders (Google Scholar: 130+ pubs, Total Citations ~ 7000, h-index 36, i10-index 97). His contributions have been recognized with numerous accolades, including the Paul Dudley White International Scholar Award and the Wayne G. Watson Award for Biologic or Experimental Research.
Dr. Nemer’s academic service extends to mentorship, curriculum development, and membership on prestigious committees and boards, including editorial roles for high-impact journals like Scientific Reports and Frontiers in Cardiovascular Medicine. He is also an elected member of the Royal Society of Medicine (UK) and Sigma Xi.
In addition to his academic and scientific endeavors, Dr. Nemer is deeply committed to fostering innovation, advancing interdisciplinary collaborations, and promoting excellence in education and research. His visionary approach continues to shape the fields of genomics and precision medicine.
